Literature DB >> 2869812

The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro.

A Daugherty, K N Frayn, W S Redfern, B Woodward.   

Abstract

The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in vivo and in vitro was studied using coronary artery ligation in the rat. Increases in plasma catecholamine concentrations during coronary artery ligation in pentobarbitone-anaesthetized animals were prevented by either acute adrenalectomy or chronic adrenal demedullation, but these procedures did not protect against the occurrence of ventricular arrhythmias. Thus plasma catecholamines were not obligatory mediators of arrhythmogenesis. Three protocols were used in vitro to evaluate the possible influence of intramyocardial release of noradrenaline, produced by the local conditions of ischaemia, on the production of ventricular arrhythmias. During coronary artery ligation in isolated perfused hearts, no enhanced output of 3H could be detected from [3H]-noradrenaline loaded hearts, even in the presence of inhibitors of catecholamine uptake processes, although washout of lactate from ischaemic regions was readily demonstrable. Both optical isomers of propranolol were equally effective in reducing the incidence of arrhythmias, implying a non-specific effect, since the (+)-isomer possesses considerably less beta-adrenoceptor blocking activity. The equipotency of optical isomers of propranolol combined with a lack of effect of atenolol suggested that arrhythmia production was not a consequence of beta-adrenoceptor stimulation. The alpha-adrenoceptor blockers phentolamine and prazosin, both exerted antiarrhythmic actions of similar potency, but phenoxybenzamine and trimazosin had no significant effects. An evaluation of the pharmacological properties of the alpha-adrenoceptor blockers showed that those drugs which had demonstrable local anaesthetic properties also exerted significant antiarrhythmic effects. No relationship was found between potency of alpha-adrenoceptor blockade and antiarrhythmic efficacy. The overall conclusion from these multifaceted approaches was that catecholamines were not necessary mediators of the early phase of ventricular arrhythmias in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869812      PMCID: PMC1916887          DOI: 10.1111/j.1476-5381.1986.tb10180.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  Effects of phentolamine on electrophysiologic properties of isolated canine purkinje fibers.

Authors:  M R Rosen; H Gelband; B F Hoffman
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

3.  Propranolol in the prevention of ventricular fibrillation due to experimental coronary artery occlusion. Observations on its mode of action.

Authors:  R E Fearon
Journal:  Am J Cardiol       Date:  1967-08       Impact factor: 2.778

4.  Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation.

Authors:  P A Ebert; R B Vanderbeek; R J Allgood; D C Sabiston
Journal:  Cardiovasc Res       Date:  1970-04       Impact factor: 10.787

5.  Possible myocardial adaptation to acute coronary occlusion. Relation to catecholamines.

Authors:  S N Dutta; W M Booker
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-05

6.  Myocardial metabolism and function during ischaemia: response to 1-noradrenaline.

Authors:  T J Regan; A Markov; H A Oldewurtel; W M Burke
Journal:  Cardiovasc Res       Date:  1970-07       Impact factor: 10.787

7.  Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat.

Authors:  J Scheuer; S W Stezoski
Journal:  Circ Res       Date:  1970-11       Impact factor: 17.367

8.  Role of the nervous system in the arrhythmias produced by coronary occlusion in the cat.

Authors:  R A Gillis
Journal:  Am Heart J       Date:  1971-05       Impact factor: 4.749

9.  Direct release of myocardial catecholamines into the left heart chambers : the enhancing effect of acute coronary occlusion.

Authors:  J Lammerant; P De Herdt; C De Schryver
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-09

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  20 in total

1.  Effects of HNS-32, a novel antiarrhythmic drug, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats.

Authors:  M Saitoh; N N Aye; S Komori; T Nakazawa; K Hashimoto
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

2.  Comparative study of the effects of acebutolol, atenolol, d-propranolol and dl,-propranolol on the alterations in energy metabolism caused by ischemia and reperfusion: a 31P NMR study on the isolated rat heart.

Authors:  N Lavanchy; J Martin; A Rossi
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

3.  Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart.

Authors:  M C Butterfield; R Chess-Williams
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.

Authors:  Ingo Staudacher; Lu Wang; Xiaoping Wan; Sabrina Obers; Wolfgang Wenzel; Frank Tristram; Ronald Koschny; Kathrin Staudacher; Jana Kisselbach; Patrick Koelsch; Patrick A Schweizer; Hugo A Katus; Eckhard Ficker; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

5.  Pheochromocytoma associated ventricular tachycardia blocked with atenolol.

Authors:  R D Michaels; J H Hays; J T O'Brian; K M Shakir
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

6.  Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial alpha-adrenoceptor responsiveness.

Authors:  R Chess-Williams; S J Coker
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Attenuation by phentolamine of hypoxia and levcromakalim-induced abbreviation of the cardiac action potential.

Authors:  D Tweedie; G Boachie-Anash; C G Henderson; K A Kane
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.

Authors:  R B Jones; G Frodsham; K Dickinson; G A Foster
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Desipramine prevents cardiac gap junction uncoupling.

Authors:  Joanna Jozwiak; Anna Dietze; Rajiv Grover; Alex Savtschenko; Christian Etz; Friedrich W Mohr; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-09-11       Impact factor: 3.000

10.  Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia.

Authors:  A M Dart; R A Riemersma; A Schömig; A Ungar
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.